Clinical Efficacy and Safety Comparison of Rivaroxaban and Dabigatran for Nonvalvular Atrial Fibrillation Patients Undergoing Percutaneous Left Atrial Appendage Closure Operation

Objective: Due to the clinical complexity of warfarin, novel oral anticoagulation (NOAC) has been a feasible and safe alternative anticoagulant approach during left atrial appendage closure (LAAC). This study was designed to compare the efficacy and safety of rivaroxaban and dabigatran for nonvalvul...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiaoye, Zhang, Xiaochun, Jin, Qinchun, Xue, Ying, Lu, Wenjing, Ge, Junbo, Zhou, Daxin, Lv, Qianzhou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8249758/
https://www.ncbi.nlm.nih.gov/pubmed/34220493
http://dx.doi.org/10.3389/fphar.2021.614762

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8249758/
https://www.ncbi.nlm.nih.gov/pubmed/34220493
http://dx.doi.org/10.3389/fphar.2021.614762

Ejemplares similares